Literature DB >> 7142750

Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics.

M P Glauser, P Francioli.   

Abstract

Because bacteriostatic concentrations of vancomycin are effective in prophylaxis against endocarditis due to Streptococcus sanguis in rats, the efficacy of three other bacteriostatic antibiotics was investigated against three different streptococcal species that cause subacute endocarditis in humans: Streptococcus intermedius. S. sanguis, and Streptococcus mitior. Rats were challenged by intravenous injection of 2 x 10(5) colony-forming units of streptococci 24 hr after intracardiac insertion of a transaortic catheter and 30 min after intravenous injection of various doses of clindamycin, erythromycin, and doxycycline. Significant protection was achieved with all three antibiotics, but only clindamycin was fully effective against all three species at doses that simulated serum levels achievable in humans after oral administration. Endocarditis was prevented by antibiotic concentrations in serum far below minimal bactericidal concentrations for these streptococci. Furthermore, serum at the time of bacterial challenge was not bactericidal. Therefore, single doses of nonbactericidal antibiotics prevented endocarditis in rats by mechanisms other than bacterial killing.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7142750     DOI: 10.1093/infdis/146.6.806

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Role of adherence in infective endocarditis.

Authors:  M A Kielhofner; R J Hamill
Journal:  Tex Heart Inst J       Date:  1989

2.  Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.

Authors:  M S Rouse; J M Steckelberg; C M Brandt; R Patel; J M Miro; W R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Tolerance and efficacy of parenterally administered penicillin-streptomycin and orally administered amoxicillin or penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

Authors:  R Pujadas; E Escriva; J Jane; J Argimon; F Fernandez; P Fava; M Galera; J Garau
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 4.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  E Tuomanen; D T Durack; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  [Antimicrobial prophylaxis to prevent endocarditis: what has changed?].

Authors:  Dieter Horstkotte; Cornelia Piper
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

6.  Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis.

Authors:  R Pujadas; E Escriva; J Jane; M C Galera; P Fava; J Garau; B Mirelis
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

7.  RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci.

Authors:  F L'Hériteau; J M Entenza; F Lacassin; C Leport; M P Glauser; P Moreillon
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.